Pharmacology of polymorphic variants of the human 5-HT1A receptor

Biochemical Pharmacology

Volumn 67, Issue 3, 2004, Pages 479-490

  Del Tredici, Andria L ^a   Schiffer, Hans H ^a   Burstein, Ethan S ^a   Lameh, Jelveh ^a   Mohell, Nina ^a   Hacksell, Uli ^a   Brann, Mark R ^a,b   Weiner, David M ^a,b,c  

^a ACADIA PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 HT; 5 HT1A receptor; cSNP; Polymorphism; Serotonin; Site directed mutagenesis

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CARBOXYTRYPTAMINE; ALANINE; AMINO ACID; BUSPIRONE; CLOROTEPINE; ERGOMETRINE; LIGAND; LISURIDE; METITEPINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OXYMETAZOLINE; PERGOLIDE; PINDOLOL; RAUWOLSCINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SERTINDOLE; SPIPERONE; TERGURIDE; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; ASSAY; CELL TRANSFORMATION; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MEMBRANE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 1242331019     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.09.030     Document Type: Article

References (49)

1. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., Kobilka T.S., Francke U., Lefkowitz R.J., Caron M.G. An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature. 329(6134):1987;75-79.
2. De Vivo M., Maayani S. Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238(1):1986;248-253.
3. Marcinkiewicz M., Verge D., Gozlan H., Pichat L., Hamon M. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res. 291(1):1984;159-163.
4. Gozlan H., El Mestikawy S., Pichat L., Glowinski J., Hamon M. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 305(5930):1983;140-142.
5. Gingrich J.A., Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl.). 155(1):2001;1-10.
6. Sarnyai Z., Sibille E.L., Pavlides C., Fenster R.J., McEwen B.S., Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors. Proc. Natl. Acad. Sci. U.S.A. 97(26):2000;14731-14736. [In Process Citation].
7. Peroutka S.J. Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol. Psychiatry. 20(9):1985;971-979.
8. Feighner J.P., Merideth C.H., Hendrickson G.A. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J. Clin. Psychiatry. 43(12 Pt 2):1982;103-108.
9. Goldberg H.L., Finnerty R.J. The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am. J. Psychiatry. 136(9):1979;1184-1187.
10. Artigas F., Perez V., Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen. Psychiatry. 51(3):1994;248-251.
11. Berman R.M., Darnell A.M., Miller H.L., Anand A., Charney D.S. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Am. J. Psychiatry. 154(1):1997;37-43.
12. 1A receptor: a site-directed mutation study. FEBS Lett. 312(2/3):1992;259-262.
13. Chanda P.K., Minchin M.C., Davis A.R., Greenberg L., Reilly Y., McGregor W.H., Bhat R., Lubeck M.D., Mizutani S., Hung P.P. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor. Mol. Pharmacol. 43(4):1993;516-520.
14. Guan X.M., Peroutka S.J., Kobilka B.K. Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors. Mol. Pharmacol. 41(4):1992;695-698.
15. i to Gs in a ligand-dependent manner. J. Neurochem. 75(3):2000;1283-1293.
16. Lembo P.M., Albert P.R. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C. Mol. Pharmacol. 48(6):1995;1024-1029.
17. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Lane C.R., Lim E.P., Kalayanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22(3):1999;231-238.
18. Halushka M.K., Fan J.B., Bentley K., Hsie L., Shen N., Weder A., Cooper R., Lipshutz R., Chakravarti A. Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat. Genet. 22(3):1999;239-247.
19. 1A receptor gene. Psychiatry Genet. 9(2):1999;105-106.
20. 1A gene. Am. J. Med. Genet. 60(5):1995;393-399.
21. 1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28. Biochem. Biophys. Res. Commun. 210(2):1995;530-536.
22. Lam S., Shen Y., Nguyen T., Messier T.L., Brann M., Comings D., George S.R., O'Dowd B.F. A serotonin receptor gene (5HT1A) variant found in a Tourette's syndrome patient. Biochem. Biophys. Res. Commun. 219(3):1996;853-858.
23. Weiner D.M., Burstein E.S., Nash N., Croston G.E., Currier E.A., Vanover K.E., Harvey S.C., Donohue E., Hansen H.C., Andersson C.M., Spalding T.A., Gibson D.F., Krebs-Thomson K., Powell S.B., Geyer M.A., Hacksell U., Brann M.R. 5-Hydroxytryptamine2A receptor inverse agonists as antipsychotics. J. Pharmacol. Exp. Ther. 299(1):2001;268-276.
24. i alpha. Nature. 363(6426):1993;274-276.
25. Burstein E.S., Spalding T.A., Hill-Eubanks D., Brann M. Structure-function of muscarinic receptor coupling to G proteins. Random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins. J. Biol. Chem. 270(7):1995 February 17;3141-3146.
26. Burford N.T., Tobin A.B., Nahorski S.R. Coupling of muscarinic m1, m2 and m3 acetylcholine receptors, expressed in Chinese hamster ovary cells, to pertussis toxin-sensitive/insensitive guanine nucleotide-binding proteins. Eur. J. Pharmacol. 289(2):1995;343-351.
27. Harada S., Okubo T., Tsutsumi M., Takase S., Muramatsu T. Investigation of genetic risk factors associated with alcoholism. Alcohol. Clin. Exp. Res. 20(Suppl. 9):1996;293A-296A.
28. 1A receptor gene and association analysis in schizophrenia. Am. J. Med. Genet. 81(5):1998;434-439.
29. Aune T.M., McGrath K.M., Sarr T., Bombara M.P., Kelley K.A. Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J. Immunol. 151(3):1993;1175-1183.
30. Price R.D., Weiner D.M., Chang M.S., Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor alters receptor-mediated activation of G13 protein. J. Biol. Chem. 276(48):2001;44663-44668.
31. Roth B.L., Lopez E., Patel S., Kroeze W.K. The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches? The Neuroscientist. 8(4):2000;252-262.
32. 35S ]GTPgammaS binding study Eur. J. Pharmacol. 355(2/3):1998;245-256.
33. Mulligan R.C., Berg P. Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci. U.S.A. 78(4):1981;2072-2076.
34. 1A receptor variant with the Ile28Val substitution in the extracellular domain. Naunyn Schmiedebergs Arch. Pharmacol. 352(4):1995;455-458.
35. Rotondo A., Nielsen D.A., Nakhai B., Hulihan-Giblin B., Bolos A., Goldman D. Agonist-promoted down-regulation and functional desensitization in two naturally occurring variants of the human serotonin1A receptor. Neuropsychopharmacology. 17(1):1997;18-26.
36. 1A receptor is intact in mood disorders. Neuropsychopharmacology. 12(3):1995;263-268.
37. 1A receptor gene structural polymorphisms and suicide victims. Am. J. Med. Genet. 114(4):2002;423-425.
38. Arias B., Arranz M.J., Gasto C., Catalan R., Pintor L., Gutierrez B., Kerwin R.W., Fananas L. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression. Mol. Psychiatry. 7(9):2002;930-932.
39. Kenakin T.P., Morgan P.H. Theoretical effects of single and multiple transducer receptor coupling proteins on estimates of the relative potency of agonists. Mol. Pharmacol. 35(2):1989;214-222.
40. 1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn Schmiedebergs Arch. Pharmacol. 345(3):1992;257-263.
41. i subtype specificity of the 5-HT1A receptor. J. Biol. Chem. 274(23):1999;16444-16450.
42. 3H ]lisuride labels free receptor and receptor coupled to G protein J. Neurochem. 65(5):1995;1909-1916.
43. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 289(5480):2000;739-745. [see comments].
44. Ji T.H., Grossmann M., Ji I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 273(28):1998;17299-17302.
45. Spalding T.A., Trotter C., Skjaerbaek N., Messier T.L., Currier E.A., Burstein E.S., Li D., Hacksell U., Brann M.R. Discovery of an ectopic activation site on the M(1) muscarinic receptor. Mol. Pharmacol. 61(6):2002;1297-1302.
46. Rana B.K., Shiina T., Insel P.A. Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41:2001;593-624.
47. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry. 43(8):1998;547-573.
48. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 416(6879):2002;396-400.
49. 1A structural variants with allele-specific amplification and electrochemiluminescent detection. Hum. Mutat. 7(2):1996;135-143.